EUVIMEDEUVIMED entdecken
Crossref

IGF1R and HIF-1α Gene Silencing Inhibits Cancer Cell Growth

Shiva Abolhasani, Sepideh Javadi, Hadi Hassannia, Ghasem Ghalamfarsa, Mohammad Hojjat-Farsangi, Farhad Jadidi-Niaragh

International Journal of Drug Research in Clinics · 2023

DOI: 10.34172/ijdrc.2023.e17 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Research in Clinics, 2023. Verfasst von Shiva Abolhasani und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

According to several studies, hypoxia-inducible factor-1α (HIF-1α) and insulin-like growth factor 1 receptor (IGF1R) promote cancer progression and drug resistance. The overexpression of IGF1R and HIF-1 α is observed in various cancers, including breast and colon cancers. Thus, we tried to inhibit the progression of tumor cells by blocking IGF1R and HIF-1α.

Methods

This study used Lipofectamine to transfect small interfering RNAs (siRNAs) into tumor cells. We treated murine mammary carcinoma (4T1) and murine colon carcinoma (CT26) cells with anti-IGF1R and anti-HIF-1 siRNAs. The real-time polymerase chain reaction (PCR) assay studied the impact of siRNA transfection on the mRNA levels of affected factors. Moreover, the viability of cancer cells was investigated by the MTT assay.

Results

The investigations demonstrated that the mRNA levels of IGF1R and HIF-1α strongly reduced in tumor cell lines following siRNA transfection. Moreover, silencing IGF1R and HIF-1 additively downregulated cell viability in cancer cell lines.

Conclusion

These findings imply that cancer combination therapy based on IGF1R and HIF-1α targeting may be a novel promising approach for the immunotherapy of breast and colorectal cancers; however, more study is required.

Zitieren

APA

Abolhasani, S., Javadi, S., Hassannia, H., Ghalamfarsa, G., Hojjat-Farsangi, M., & Jadidi-Niaragh, F. (2023). IGF1R and HIF-1α Gene Silencing Inhibits Cancer Cell Growth. International Journal of Drug Research in Clinics. https://doi.org/10.34172/ijdrc.2023.e17

Vancouver

Abolhasani S, Javadi S, Hassannia H, Ghalamfarsa G, Hojjat-Farsangi M, Jadidi-Niaragh F. IGF1R and HIF-1α Gene Silencing Inhibits Cancer Cell Growth. International Journal of Drug Research in Clinics. 2023. doi:10.34172/ijdrc.2023.e17

BibTeX
@article{Abolhasani2023,
  author = {Abolhasani, Shiva and Javadi, Sepideh and Hassannia, Hadi and Ghalamfarsa, Ghasem and Hojjat-Farsangi, Mohammad and Jadidi-Niaragh, Farhad},
  title = {IGF1R and HIF-1α Gene Silencing Inhibits Cancer Cell Growth},
  journal = {International Journal of Drug Research in Clinics},
  year = {2023},
  doi = {10.34172/ijdrc.2023.e17}
}
Kostenlos starten →